Clinical Trial Details


Research Study Summary

A study to investigate the efficacy, safety, and tolerability of an investigational drug (JNJ-42165279) in patients with social anxiety disorder


Doctors are testing the safety, effectiveness and tolerability of an oral investigational medication to determine if it helps control the symptoms of social anxiety disorder.

Participants will receive the study drug and all study-related care at no cost.

To Learn more

CW ID: 225743
Date Last Changed: October 11, 2017

Clinical Trial Snapshot

Both Male and Female
18 to 64 Years
Overall Status
20 Weeks
Facility Type


  • Diagnosed with Social Anxiety Disorder
  • Are 18 - 64 years of age
  • Females must be of non-childbearing potential
  • Has performance only social anxiety.
  • Is currently receiving psychotherapy.

More Info

Study participation involves a screening visit followed by a 12 week treatment period and a follow-up visit between one to four weeks after you take the final dose. You cannot take psychotropic medications such as mood stabilizers or anti-anxiety medications during the study.

For more information, please email us at:


Beverley Hisee
Lyell McEwin Hospital
Located in
Elizabeth Vale 5112
Phone: 08 8182 9554

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.